SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Norah A. Terrault, Natalie H. Bzowej, Kyong-Mi Chang, Jessica P. Hwang, Maureen M. Jonas, M. Hassan Murad, AASLD guidelines for treatment of chronic hepatitis B, Hepatology, 2016, 63, 1
  2. 2
    U. S. Gill, A. Zissimopoulos, S. Al-Shamma, K. Burke, M. J. W. McPhail, D. A. Barr, Y. N. Kallis, R. T. C. Marley, P. Kooner, G. R. Foster, P. T. F. Kennedy, Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?, Journal of Infectious Diseases, 2015, 211, 3, 374

    CrossRef

  3. 3
    Lisa Hamzah, Amanda Samarawickrama, Lucy Campbell, Matthew Pope, Keith Burling, Karen Walker-Bone, Yvonne Gilleece, Martin Fisher, Frank A. Post, Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients, AIDS, 2015, 29, 14, 1785

    CrossRef

  4. 4
    Paul Nash, Paul Willis, Andrea Tales, Thomas Cryer, Sexual health and sexual activity in later life, Reviews in Clinical Gerontology, 2015, 25, 01, 22

    CrossRef

  5. 5
    Jean C. Yombi, Anton Pozniak, Marta Boffito, Rachael Jones, Saye Khoo, Jeremy Levy, Frank A. Post, Antiretrovirals and the kidney in current clinical practice, AIDS, 2014, 28, 5, 621

    CrossRef

  6. 6
    Lourdes Mateo, Susana Holgado, Maria Luisa Mariñoso, Ricard Pérez-Andrés, Anna Bonjoch, Joan Romeu, Alejandro Olivé, Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients, Clinical Rheumatology, 2014,

    CrossRef

  7. 7
    Katrin F. Koenig, Stefan Kalbermatter, Thomas Menter, Peter Graber, Denes Kiss, Recurrent bone fractures due to tenofovir-induced renal phosphate wasting, Scandinavian Journal of Infectious Diseases, 2014, 46, 3, 221

    CrossRef

  8. 8
    Atefeh Jafari, Hossein Khalili, Simin Dashti-Khavidaki, Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention, European Journal of Clinical Pharmacology, 2014, 70, 9, 1029

    CrossRef

  9. 9
    M Bickel, P Khaykin, C Stephan, K Schmidt, M Buettner, K Amann, T Lutz, P Gute, A Haberl, H Geiger, HR Brodt, O Jung, Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration, HIV Medicine, 2013, 14, 10
  10. 10
    D. Gibellini, M. Borderi, E. Vanino, A. Clò, S. Morini, L. Calza, M. C. Re, Pl. Viale, Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy, Clinical Reviews in Bone and Mineral Metabolism, 2012, 10, 4, 236

    CrossRef

  11. 11
    Motoyuki Tanaka, Takao Setoguchi, Yasuhiro Ishidou, Yoshiya Arishima, Masataka Hirotsu, Yoshinobu Saitoh, Shunsuke Nakamura, Hironori Kakoi, Satoshi Nagano, Masahiro Yokouchi, Junichi Kamizono, Setsuro Komiya, Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report, Diagnostic Pathology, 2012, 7, 1, 108

    CrossRef

  12. 12
    Jacek Kowalski, Grażyna Cholewińska, An increased risk of osteoporosis in a HIV-infected patient in the era of HAART. Case report analysis, HIV & AIDS Review, 2011, 10, 2, 47

    CrossRef

  13. 13
    Zygimantas C Alsauskas, Raj Kiran Medapalli, Michael J Ross, Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients, Expert Opinion on Pharmacotherapy, 2011, 12, 5, 691

    CrossRef

  14. 14
    Claire Naftalin, Bavithra Nathan, Lisa Hamzah, Frank A. Post, HIV-associated kidney disease in the context of an aging population, Sexual Health, 2011, 8, 4, 485

    CrossRef

  15. 15
    Alessandra Viganò, Giorgio Bedogni, Valeria Manfredini, Vania Giacomet, Chiara Cerini, Francesca di Nello, Francesca Penagini, Cristiana Caprio, Gian Vincenzo Zuccotti, Long-Term Renal Safety of Tenofovir Disoproxil Fumarate in Vertically HIV-Infected Children, Adolescents and Young Adults, Clinical Drug Investigation, 2011, 31, 6, 407

    CrossRef

  16. 16
    Ana Angeles Pérez-Rivera, Pilar Sáez, Eva León, Fernando Lozano de León-Naranjo, Mujer con infección por el VIH, intensos dolores osteomusculares y debilidad generalizada, Enfermedades Infecciosas y Microbiología Clínica, 2011, 29, 4, 308

    CrossRef

  17. 17
    J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2715

    CrossRef

  18. 18
    Rose-Marie Javier, David Rey, Os, infection par le VIH et antirétroviraux, Revue du Rhumatisme Monographies, 2011, 78, 2, 101

    CrossRef

  19. 19
    Frank A Post, Eugene V McCloskey, Juliet E Compston, Christine A Bowman, Phillip E Hay, Margaret A Johnson, Patrick WG Mallon, Barry S Peters, Amanda Samarawickrama, Gareth Tudor-Williams, Prevention of bone loss and management of fracture risk in HIV-infected individuals: case studies and recommendations for different patient subgroups, Future Virology, 2011, 6, 6, 769

    CrossRef

  20. 20
    Pere Soler-Palacín, Susana Melendo, Antoni Noguera-Julian, Claudia Fortuny, María L Navarro, María J Mellado, Lourdes Garcia, Sonia Uriona, Andrea Martín-Nalda, Concepció Figueras, Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens, AIDS, 2011, 25, 2, 171

    CrossRef

  21. 21
    Derek Yu, Jenny Heathcote, Tenofovir in the treatment of chronic hepatitis B, Therapy, 2011, 8, 5, 527

    CrossRef

  22. 22
    Beatriz Fernandez-Fernandez, Ana Montoya-Ferrer, Ana B. Sanz, Maria D. Sanchez-Niño, Maria C. Izquierdo, Jonay Poveda, Valeria Sainz-Prestel, Natalia Ortiz-Martin, Alejandro Parra-Rodriguez, Rafael Selgas, Marta Ruiz-Ortega, Jesus Egido, Alberto Ortiz, Tenofovir Nephrotoxicity: 2011 Update, AIDS Research and Treatment, 2011, 2011, 1

    CrossRef

  23. 23
    Young Kul Jung, Jong Eun Yeon†, Jong Hwan Choi†, Chung Ho Kim†, Eun Suk Jung†, Ji Hoon Kim†, Jong Jae Park†, Jae Seon Kim†, Young-Tae Bak†, Kwan Soo Byun†, Fanconi's Syndrome Associated with Prolonged Adefovir Dipivoxil Therapy in a Hepatitis B Virus Patient, Gut and Liver, 2010, 4, 3, 389

    CrossRef

  24. 24
    David Cooper, Gail Matthews, Kucers' The Use of Antibiotics Sixth Edition, 2010,

    CrossRef

  25. 25
    Robert Perrillo, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  26. 26
    Mahyar Lavae-Mokhtari, Somayeh Mohammad-Khani, Reinhold Ernst Schmidt, Matthias Stoll, Akutes Nierenversagen und Hyperkalzämie unter tenofovirhaltiger antiretroviraler Therapie bei einer Patientin mit AIDS und Immunrekonstitutionssyndrom nach niedrigdosierter Vitamin-D-Substitution, Medizinische Klinik, 2009, 104, 10, 810

    CrossRef

  27. 27
    Julien Paccou, Nathalie Viget, Isabelle Legrout-Gérot, Yazdan Yazdanpanah, Bernard Cortet, Bone loss in patients with HIV infection, Joint Bone Spine, 2009, 76, 6, 637

    CrossRef

  28. 28
    Lisa Hamzah, Frank A. Post, HIV and kidney disease, Medicine, 2009, 37, 7, 365

    CrossRef

  29. 29
    Julien Paccou, Nathalie Viget, Isabelle Legrout-Gérot, Yazdan Yazdanpanah, Bernard Cortet, Les ostéopathies fragilisantes des patients infectés par le VIH, Revue du Rhumatisme, 2009, 76, 12, 1293

    CrossRef

  30. 30
    Marco Borderi, Davide Gibellini, Fabio Vescini, Elisa De Crignis, Laura Cimatti, Carlo Biagetti, Livia Tampellini, Maria C Re, Metabolic bone disease in HIV infection, AIDS, 2009, 23, 11, 1297

    CrossRef

  31. 31
    Dirk Lebrecht, Ana C Venhoff, Janbernd Kirschner, Thorsten Wiech, Nils Venhoff, Ulrich A Walker, Mitochondrial Tubulopathy in Tenofovir Disoproxil Fumarate-Treated Rats, JAIDS Journal of Acquired Immune Deficiency Syndromes, 2009, 51, 3, 258

    CrossRef

  32. 32
    Ana Lúcia Lei Munhoz Lima, Alexandre Leme Godoy, Priscila Rosalba Domingos Oliveira, Ricardo Gomes Gobbi, Camila de Almeida Silva, Patricia Bernardelli Martino, Eliana Bataggia Gutierrez, Maria Clara Gianna, Gilberto Luis Camanho, ORTHOPEDIC COMPLICATIONS IN HIV PATIENTS, Revista Brasileira de Ortopedia (English Edition), 2009, 44, 3, 186

    CrossRef

  33. 33
    Nils Venhoff, Ulrich Andreas Walker, Pathogenesis of bone disorders in HIV infection, International Journal of Clinical Rheumatology, 2009, 4, 2, 147

    CrossRef

  34. 34
    Robert J. Fontana, Side effects of long-term oral antiviral therapy for hepatitis B, Hepatology, 2009, 49, S5
  35. 35
    Orson W. Moe, Donald W. Seldin, Michel Baum, Genetic Diseases of the Kidney, 2009,

    CrossRef

  36. 36
    F. Jiménez Zorzo, C. Beltrán Audera, C. Bruscas Izu, Osteomalacia hipofosfatémica en un paciente infectado por VIH en tratamiento con tenofovir, Revista Española de Enfermedades Metabólicas Óseas, 2008, 17, 2, 22

    CrossRef

  37. 37
    U. A. Walker, A. Tyndall, T. Daikeler, Rheumatic conditions in human immunodeficiency virus infection, Rheumatology, 2008, 47, 7, 952

    CrossRef

  38. 38
    Alexandre B. Libório, Lúcia Andrade, Leonardo V.B. Pereira, Talita R.C. Sanches, Maria H. Shimizu, Antonio C. Seguro, Rosiglitazone reverses tenofovir-induced nephrotoxicity, Kidney International, 2008, 74, 7, 910

    CrossRef

  39. 39
    A. Pozniak, Tenofovir: what have over 1 million years of patient experience taught us?, International Journal of Clinical Practice, 2008, 62, 8
  40. 40
    Ian J. Woolley, Michelle L. Giles, Jayne E. Howard, Tony M. Korman, Unrecognised vitamin D deficiency: low concentrations in African migrants with HIV in Australia, Sexual Health, 2008, 5, 4, 375

    CrossRef

  41. 41
    Jay H. Hoofnagle, Edward Doo, T. Jake Liang, Russell Fleischer, Anna S.F. Lok, Management of hepatitis B: Summary of a clinical research workshop, Hepatology, 2007, 45, 4
  42. 42
    Michael D Gitman, David Hirschwerk, Cindy H Baskin, Pravin C Singhal, Tenofovir-induced kidney injury, Expert Opinion on Drug Safety, 2007, 6, 2, 155

    CrossRef

  43. 43
    J Winston, DH Shepp, Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use, HIV Medicine, 2006, 7, 7
  44. 44
    K Buchacz, JT Brooks, T Tong, AC Moorman, RK Baker, SD Holmberg, A Greenberg, Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy, HIV Medicine, 2006, 7, 7
  45. 45
    Svetlana Karie, Vincent Launay-Vacher, Hassane Izzedine, Gilbert Deray, Néphrotoxicité des médicaments: veille bibliographique janvier 2003–décembre 2005, Néphrologie & Thérapeutique, 2006, 2, 6, 368

    CrossRef

  46. 46
    F. Bentaberry, N. Bernard, F. Bonnet, P. Morlat, Ostéomalacie dû à un syndrome de Fanconi au cours d'un traitement par ténofovir, La Revue de Médecine Interne, 2006, 27, S407

    CrossRef

  47. 47
    F. Bentaberry, N. Bernard, A. Monnier, F. Bonnet, P. Morlat, Ostéomalacie dû à un syndrome de Fanconi au cours d'un traitement par ténofovir, Revue du Rhumatisme, 2006, 73, 10-11, 1156

    CrossRef